Bicara Therapeutics Inc. · NASDAQ:BCAX
T. Rowe Price Investment Management, Inc. reported a 10.10% stake in Bicara Therapeutics Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed Apr 8, 2026
T. Rowe Price Investment Management, Inc. reported a 10.10% stake in Bicara Therapeutics Inc., 6,605,780 shares, as a passive investor on Mar 31, 2026. Filed Apr 8, 2026 (Schedule 13G/A).
- Stake
- 10.10%
- Shares
- 6,605,780
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 10.10% | 6,605,780 |
Source
Related
- Bicara Therapeutics Inc.
- T. Rowe Price Investment Management, Inc.
- Bicara Therapeutics Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2026
- Schedule 13G · T. Rowe Price Investment Management, Inc. · Feb 17, 2026
- Form 4 · Cohlhepp Ryan · Sep 10, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Hyep Ivan · Aug 12, 2026
- Form 4 · Mazumdar Claire · Aug 12, 2026
- Form 4 · Cohlhepp Ryan · Aug 12, 2026